{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T08:10:28Z","timestamp":1743581428326,"version":"3.40.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9-10","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s10354-012-0072-5","type":"journal-article","created":{"date-parts":[[2012,6,20]],"date-time":"2012-06-20T09:31:24Z","timestamp":1340184684000},"page":"191-195","source":"Crossref","is-referenced-by-count":4,"title":["First trimester serum markers to predict preeclampsia","Serum-Marker im ersten Trimenon zur Vorhersage der Pr\u00e4eklampsie"],"prefix":"10.1007","volume":"162","author":[{"given":"Berthold","family":"Huppertz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"Suppl","key":"72_CR1","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.placenta.2010.11.022","volume":"32","author":"I Cetin","year":"2011","unstructured":"Cetin I, Huppertz B, Burton G, et al. Pregenesys pre-eclampsia markers consensus meeting: what do we require from markers, risk assessment and model systems to tailor preventive strategies? Placenta, 32 (Suppl): S4\u201316, 2011","journal-title":"Placenta"},{"key":"72_CR2","doi-asserted-by":"crossref","unstructured":"ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, 2002. American College of Obstetricians and Gynecologists. ACOG Committee on Obstetric Practice. Int J Gynaecol Obstet, 77: 67\u201375, 2002","DOI":"10.1016\/S0020-7292(02)80002-9"},{"key":"72_CR3","unstructured":"World Health Organization. Make Every Mother and Child Count. World Health Report, 2005. Geneva, Switzerland: World Health Organization; 2005"},{"key":"72_CR4","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/HYPERTENSIONAHA.107.107607","volume":"51","author":"B Huppertz","year":"2008","unstructured":"Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension, 51: 970\u2013975, 2008","journal-title":"Hypertension"},{"key":"72_CR5","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.1471-0528.2008.01902.x","volume":"115","author":"R Gonen","year":"2008","unstructured":"Gonen R, Shahar R, Grimpel YI, et al. Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study. BJOG, 115: 1465\u20131472, 2008","journal-title":"BJOG"},{"key":"72_CR6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000151344","volume":"24","author":"B Huppertz","year":"2008","unstructured":"Huppertz B, Sammar M, Chefetz I, et al. Longitudinal determination of serum PP13 during development of preeclampsia. Fetal Diagn Therapy, 24: 230\u2013236, 2008","journal-title":"Fetal Diagn Therapy"},{"issue":"Suppl A","key":"72_CR7","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.placenta.2007.11.016","volume":"29","author":"CW Redman","year":"2008","unstructured":"Redman CW, Sargent IL. Circulating microparticles in normal pregnancy and pre-eclampsia. Placenta, 29 (Suppl A): S73\u2013S77, 2008","journal-title":"Placenta"},{"key":"72_CR8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.placenta.2004.11.007","volume":"27","author":"D Goswami","year":"2006","unstructured":"Goswami D, Tannetta DS, Magee LA, et al. Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta, 27: 56\u201361, 2006","journal-title":"Placenta"},{"key":"72_CR9","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/00365510802474384","volume":"69","author":"RR Hamad","year":"2009","unstructured":"Hamad RR, Bremme K, Kallner A, et al. Increased levels of an apoptotic product in the sera from women with pre-eclampsia. Scand J Clin Lab Invest, 69: 204\u2013208, 2009","journal-title":"Scand J Clin Lab Invest"},{"key":"72_CR10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.placenta.2004.04.004","volume":"26","author":"AK Gupta","year":"2005","unstructured":"Gupta AK, Rusterholz C, Huppertz B, et al. A comparative study of the effect of three different syncytiotrophoblast microparticles preparations on endothelial cells. Placenta, 26: 59\u201366, 2005","journal-title":"Placenta"},{"key":"72_CR11","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1126\/science.1111726","volume":"308","author":"CW Redman","year":"2005","unstructured":"Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science, 308: 1592\u20131594, 2005","journal-title":"Science"},{"key":"72_CR12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1373\/clinchem.2009.134080","volume":"56","author":"Y Gigu\u00e8re","year":"2010","unstructured":"Gigu\u00e8re Y, Charland M, Bujold E, et al. Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review. Clin Chem, 56: 361\u2013375, 2010","journal-title":"Clin Chem"},{"key":"72_CR13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/AOG.0b013e3181e41be3","volume":"116","author":"E Bujold","year":"2010","unstructured":"Bujold E, Roberge S, Lacasse Y, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy. A meta-analysis. Obstet Gynecol, 116: 401\u2013404, 2010","journal-title":"Obstet Gynecol"},{"key":"72_CR14","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1677\/joe.0.1590459","volume":"159","author":"DE Clark","year":"1998","unstructured":"Clark DE, Smith SK, Licence D, et al. Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation. J Endocrinol, 159: 459\u2013467, 1998","journal-title":"J Endocrinol"},{"key":"72_CR15","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1210\/jc.87.6.2954","volume":"87","author":"GJ Burton","year":"2002","unstructured":"Burton GJ, Watson AL, Hempstock J, et al. Uterine glands provide histiotrophic nutrition for the human fetus during the first trimester of pregnancy. J Clin Endocrinol Metab, 87: 2954\u20132959, 2002","journal-title":"J Clin Endocrinol Metab"},{"key":"72_CR16","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/humrep\/deq035","volume":"25","author":"G Moser","year":"2010","unstructured":"Moser G, Gauster M, Orendi K, et al. Endoglandular trophoblast, an alternative route of trophoblast invasion? Analysis with novel confrontation co-culture models. Hum Reprod, 25: 1127\u20131136, 2010","journal-title":"Hum Reprod"},{"key":"72_CR17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2121-11-36","volume":"11","author":"P Pan","year":"2010","unstructured":"Pan P, Fu H, Zhang L, et al. Angiotensin II upregulates the expression of placental growth factor in human vascular endothelial cells and smooth muscle cells. BMC Cell Biol, 11: 36, 2010","journal-title":"BMC Cell Biol"},{"key":"72_CR18","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/uog.6244","volume":"32","author":"R Akolekar","year":"2008","unstructured":"Akolekar R, Zaragoza E, Poon LC, et al. Maternal serum placental growth factor at 11+0 to 13+6 weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol, 32: 732\u2013739, 2008","journal-title":"Ultrasound Obstet Gynecol"},{"key":"72_CR19","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","volume":"350","author":"RJ Levine","year":"2004","unstructured":"Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med, 350: 672\u2013683, 2004","journal-title":"N Engl J Med"},{"key":"72_CR20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14767050701830480","volume":"21","author":"R Romero","year":"2008","unstructured":"Romero R, Nien JK, Espinoza J, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med, 21: 9\u201323, 2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"72_CR21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ajog.2005.12.049","volume":"195","author":"CJ Robinson","year":"2006","unstructured":"Robinson CJ, Johnson DD, Chang EY, et al. Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia. Am J Obstet Gynecol, 195: 255\u2013259, 2006","journal-title":"Am J Obstet Gynecol"},{"key":"72_CR22","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1210\/jc.2006-2774","volume":"92","author":"H Stepan","year":"2007","unstructured":"Stepan H, Kr\u00e4mer T, Faber R. Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction. J Clin Endocrinol Metab, 92: 2831\u20132834, 2007","journal-title":"J Clin Endocrinol Metab"},{"key":"72_CR23","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/pd.2423","volume":"30","author":"NJ Cowans","year":"2010","unstructured":"Cowans NJ, Stamatopoulou A, Matwejew E, et al. First-trimester placental growth factor as a marker for hypertensive disorders and SGA. Prenat Diagn, 30: 565\u2013570, 2010","journal-title":"Prenat Diagn"},{"key":"72_CR24","doi-asserted-by":"crossref","first-page":"9731","DOI":"10.1073\/pnas.0903568106","volume":"106","author":"NG Than","year":"2009","unstructured":"Than NG, Romero R, Goodman M, et al. A primate subfamily of galectins expressed at the maternal-fetal interface that promote immune cell death. Proc Natl Acad Sci USA, 106: 9731\u20139736, 2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"72_CR25","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1177\/1933719108328615","volume":"16","author":"A Sekizawa","year":"2009","unstructured":"Sekizawa A, Purwosunu Y, Yoshimura S, et al. PP13 mRNA expression in trophoblasts from preeclamptic placentas. Reprod Sci, 16: 408\u2013413, 2009","journal-title":"Reprod Sci"},{"issue":"Suppl","key":"72_CR26","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.placenta.2010.08.014","volume":"32","author":"NJ Cowans","year":"2011","unstructured":"Cowans NJ, Stamatopoulou A, Khalil A, et al. PP13 as a marker of pre-eclampsia: a two platform comparison study. Placenta, 32 (Suppl): S37\u2013S41, 2011","journal-title":"Placenta"},{"key":"72_CR27","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/pd.2423","volume":"30","author":"NJ Cowans","year":"2010","unstructured":"Cowans NJ, Stamatopoulou A, Jaakohuhta S, et al. PP13 stability in first trimester maternal serum and whole blood. Prenat Diagn, 30: 582\u2013585, 2010","journal-title":"Prenat Diagn"},{"key":"72_CR28","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/pd.2894","volume":"31","author":"NJ Cowans","year":"2011","unstructured":"Cowans NJ, Alfthan H, Stenman UH, et al. Stability of first trimester placental growth factor in serum and whole blood. Prenat Diagn, 31: 1193\u20131197, 2011","journal-title":"Prenat Diagn"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-012-0072-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10354-012-0072-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-012-0072-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T07:57:32Z","timestamp":1743580652000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10354-012-0072-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":28,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["72"],"URL":"https:\/\/doi.org\/10.1007\/s10354-012-0072-5","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"type":"print","value":"0043-5341"},{"type":"electronic","value":"1563-258X"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}